Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus
Yukio Horikawa,Naohisa Oda,Nancy J. Cox,Xiangquan Li,Marju Orho-Melander,Manami Hara,Yoshinori Hinokio,Tom H. Lindner,Hirosato Mashima,Peter E.H. Schwarz,Laura del Bosque-Plata,Yohko Horikawa,Yukie Oda,Issei Yoshiuchi,Susan Colilla,Kenneth S. Polonsky,Shan Wei,Patrick Concannon,Naoko Iwasaki,Jan Schulze,Leslie J. Baier,Clifton Bogardus,Leif Groop,Eric Boerwinkle,Craig L. Hanis,Graeme I. Bell
DOI: https://doi.org/10.1038/79876
IF: 30.8
2000-10-01
Nature Genetics
Abstract:Type 2 or non-insulin-dependent diabetes mellitus (NIDDM) is the most common form of diabetes worldwide, affecting approximately 4% of the world's adult population. It is multifactorial in origin with both genetic and environmental factors contributing to its development. A genome-wide screen for type 2 diabetes genes carried out in Mexican Americans localized a susceptibility gene, designated NIDDM1, to chromosome 2. Here we describe the positional cloning of a gene located in the NIDDM1 region that shows association with type 2 diabetes in Mexican Americans and a Northern European population from the Botnia region of Finland. This putative diabetes-susceptibility gene encodes a ubiquitously expressed member of the calpain-like cysteine protease family, calpain-10 (CAPN10). This finding suggests a novel pathway that may contribute to the development of type 2 diabetes.
genetics & heredity